Published in Behav Neural Biol on March 01, 1985
Behavioral variability in SHR and WKY rats as a function of rearing environment and reinforcement contingency. J Exp Anal Behav (1996) 1.15
Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task. Pharmacol Biochem Behav (2009) 0.88
Regional brain variations of cytochrome oxidase activity in spontaneously hypertensive mice. Exp Brain Res (2004) 0.77
Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD). Behav Brain Res (2016) 0.75
Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol (1993) 1.04
Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.98
Preferential deamination of dopamine by an A type monoamine oxidase in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.97
The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.93
Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.93
Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses. Pharmacopsychiatry (1996) 0.90
Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.87
Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin. Pharmacol Biochem Behav (1984) 0.82
Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement. Pharmacopsychiatry (1999) 0.81
[Pharmacological research on maprotiline a new drug with antidepressive effects]. Boll Chim Farm (1973) 0.80
Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics. Pharmacopsychiatry (1986) 0.80
Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Pharmacopsychiatry (1991) 0.80
Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitor. Int J Psychiatry Clin Pract (1999) 0.79
Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients. J Neural Transm Suppl (1989) 0.78
Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112). Arzneimittelforschung (1984) 0.78
Effects of apomorphine, TL-99 and 3-PPP on yawning in rats. Neuropharmacology (1984) 0.78
Onset of action under antidepressant treatment. Eur Psychiatry (1997) 0.78
Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine. Pharmacopsychiatry (1991) 0.78
Suppressant effect of REM sleep deprivation on neophobia in normal rats and in rats with selective DSP-4 induced damage of locus coeruleus neurons. Pharmacol Biochem Behav (1985) 0.78
Antidepressants and drug-metabolizing enzymes--expert group report. Acta Psychiatr Scand (1996) 0.78
Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin. Psychopharmacology (Berl) (1983) 0.78
Inhibitory effects of propranolol and oxprenolol on excitation induced by a MAO inhibitor and reserpine in the mouse. Neuropharmacology (1976) 0.77
Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Pharmacopsychiatry (1991) 0.76
Differential effects of anxiolytics and beta-receptor blocking drugs on novelty-oriented ("neophobic") behavior in the rat. Pharmacopsychiatry (1988) 0.76
Delayed onset of action of antidepressant drugs? Survey of recent results. Eur Psychiatry (1997) 0.75
The development and the extinction of hyperthermia induced by conditioned avoidance behavior in rats. J Exp Anal Behav (1970) 0.75
Moclobemide versus fluoxetine for double depression: a randomized double-blind study. J Psychiatr Res (1997) 0.75
Detection of CNS-depressant properties of antihypertensives: validity of various test methods in rodents and estimation of therapeutic margin in hypertensive rats. Pharmacol Ther B (1979) 0.75
Septo-hippocampal system: target for substituted benzamides. Eur J Pharmacol (1982) 0.75
The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in rats. Pharmacol Biochem Behav (1983) 0.75
Onset of improvement under fluoxetine and moclobemide. Eur Psychiatry (1998) 0.75
Influence of baclofen and GABA-minetic agents on spontaneous and olfactory-bulb-ablation-induced muricidal behaviour in the rat. Arzneimittelforschung (1978) 0.75
Effects of single and repeated treatment with antidepressants on apomorphine-induced yawning in the rat: the implication of alpha-1 adrenergic mechanisms in the D-2 receptor function. Psychopharmacology (Berl) (1990) 0.75
Effect of yohimbine and its diastereoisomers on clonidine-induced depression of exploration in the rat. Eur J Pharmacol (1982) 0.75
Effect of oxprenolol on some fear-induced behavioral responses and hyperthermia in rats subjected to inescapable shocks. Psychopharmacology (Berl) (1976) 0.75
[Pharmacological studies on the effect of neuroleptics in animals after single and repeated application]. Arzneimittelforschung (1968) 0.75
Altered hindlimb extension in the rat after DSP-4: a useful marker of central noradrenergic depletion. Eur J Pharmacol (1983) 0.75
Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment. Eur J Pharmacol (1979) 0.75
Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake. Arzneimittelforschung (1986) 0.75
Stereospecificity of behavioural and biochemical responses to oxaprotiline--a new antidepressant. Adv Biochem Psychopharmacol (1982) 0.75
Influence of amphetamine and scopolamine on the catalepsy induced by diencephalic lesions in rats. Int J Neuropharmacol (1968) 0.75
Modulatory effects of baclofen muscimol and GABA on interspecific aggressive behaviour in the rat. Neuropharmacology (1978) 0.75
Increased sensitivity to neuroleptics in rats with lesions of the central nervous system. Psychopharmacologia (1972) 0.75
Facilitation of shock-induced fighting in the rat after DSP-4, a selective noradrenergic neurotoxin. Pharmacol Biochem Behav (1983) 0.75
Drug-induced suppression of conditioned hyperthermic and conditioned avoidance behavior response in rats. Psychopharmacologia (1971) 0.75
Correlation of pharmacological investigations with the clinical efficacy of antidepressant drugs. Act Nerv Super (Praha) (1974) 0.75
New pharmacological findings in depression. Psychopathology (1986) 0.75
Progress in the psychopharmacology of antidepressants: selective uptake and MAO-inhibitors. Schweiz Arch Neurol Psychiatr (1986) 0.75
Simple behavioral measures of central alpha-adrenoceptor blocking activity of drugs. Pol J Pharmacol Pharm (1985) 0.75
[Psychiatry]. Rev Med Suisse (2007) 0.75
Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase. Mod Probl Pharmacopsychiatry (1983) 0.75
Baclofen-induced modification of conditioned discriminative avoidance behaviour and contraversive turning in the rat. Eur J Pharmacol (1977) 0.75
Some aspects of the psychopharmacological activity of maprotiline (Ludiomil): effects of single and repeated treatments. J Int Med Res (1978) 0.75
Non-response to antidepressants: risk factors and therapeutic possibilities. Pharmacopsychiatry (1988) 0.75
[Psychobiology of fear]. Schweiz Rundsch Med Prax (1992) 0.75
The effects of antidepressants on aggressiveness induced by social deprivation in mice. Pharmacol Biochem Behav (1981) 0.75